US Stock MarketDetailed Quotes

OCEL ORGANICELL REGENERATIVE MEDICINE IN

Watchlist

2.750000
0.0000000.00%

15min DelayTrading Mar 4 16:00 ET

16.85MMarket Cap-13P/E (TTM)

ORGANICELL REGENERATIVE MEDICINE IN Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Oct 31, 2023

(Q4)Oct 31, 2023

(Q3)Jul 31, 2023

(Q2)Apr 30, 2023

(Q1)Jan 31, 2023

(FY)Oct 31, 2022

(Q4)Oct 31, 2022

(Q3)Jul 31, 2022

(Q2)Apr 30, 2022

(Q1)Jan 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

30.59%-2.2M

112.54%220.45K

40.82%-464.15K

-949.04%-670.85K

-129.06%-1.28M

-18.11%-3.17M

-214.18%-1.76M

-55.95%-784.3K

94.37%-63.95K

-16.00%-559.99K

Net income from continuing operations

21.47%-6.99M

63.87%-1.09M

40.69%-1.62M

-36.76%-1.99M

-35.01%-2.29M

30.26%-8.9M

-215.12%-3.02M

-93.59%-2.73M

34.98%-1.46M

79.22%-1.69M

Operating gains losses

---340.61K

----

Depreciation and amortization

46.27%486.35K

-93.72%16.5K

327.49%157.9K

739.34%156.16K

999.51%155.8K

530.92%332.51K

1,685.18%262.8K

181.42%36.94K

46.91%18.61K

16.22%14.17K

Other non cash items

35.49%368.19K

3.44%66.24K

363.79%154.05K

-72.28%61.63K

97.07%86.27K

--271.75K

--64.03K

---58.4K

--222.34K

--43.78K

Change In working capital

-43.48%788.1K

1,391.52%653.85K

154.10%47.54K

-66.36%299.91K

-138.98%-213.21K

1.69%1.39M

-43.86%43.84K

-122.13%-87.88K

758.79%891.56K

-46.97%546.9K

-Change in receivables

116.34%19.49K

99.20%-739

176.94%60.26K

-96.23%2.31K

-329.40%-42.35K

-59.46%-119.22K

-65.36%-92.48K

-361.50%-78.32K

425.33%61.44K

67.02%-9.86K

-Change in inventory

-20.60%-61.67K

68.33%-52.64K

-111.43%-5K

506.59%28.8K

-141.85%-32.83K

41.90%-51.14K

-2,047.10%-166.22K

148.90%43.72K

-27.92%-7.08K

4,966.75%78.45K

-Change in prepaid assets

184.21%99.59K

194.74%58.63K

302.04%92.36K

-139.09%-19.36K

46.77%-32.04K

-1,001.21%-118.26K

-244.55%-61.88K

-291.48%-45.71K

167.91%49.53K

-1,238.47%-60.19K

-Change in payables and accrued expense

-86.21%233.44K

-49.51%184.01K

-1,334.52%-108.54K

-65.96%268.14K

-120.10%-110.18K

10.26%1.69M

398.60%364.42K

-101.75%-7.57K

2,173.81%787.68K

-48.65%548.08K

-Change in other working capital

5,293.31%497.26K

--464.6K

--8.46K

--20.01K

143.81%4.2K

-200.00%-9.58K

--0

---9.58K

Cash from discontinued investing activities

Operating cash flow

30.59%-2.2M

112.54%220.45K

40.82%-464.15K

-949.04%-670.85K

-129.06%-1.28M

-18.11%-3.17M

-214.18%-1.76M

-55.95%-784.3K

94.37%-63.95K

-16.00%-559.99K

Investing cash flow

Cash flow from continuing investing activities

174.64%615.57K

338.53%735.22K

97.31%-3.54K

56.50%-100K

89.61%-16.12K

-94.18%-824.74K

-54.16%-308.22K

26.36%-131.48K

-229.9K

-235.32%-155.13K

Net PPE purchase and sale

96.92%-25.39K

98.14%-5.74K

97.31%-3.54K

100.00%1

89.61%-16.12K

-94.18%-824.74K

-54.16%-308.22K

26.36%-131.48K

---229.9K

-235.32%-155.13K

Net investment purchase and sale

---100K

--0

----

--0

----

Net other investing changes

--740.96K

----

Cash from discontinued investing activities

Investing cash flow

174.64%615.57K

338.53%735.22K

97.31%-3.54K

56.50%-100K

89.61%-16.12K

-94.18%-824.74K

-54.16%-308.22K

26.36%-131.48K

---229.9K

-235.32%-155.13K

Financing cash flow

Cash flow from continuing financing activities

-105.44%-415.19K

-97.09%166.95K

-103.21%-29.67K

128.74%479.29K

-236.32%-1.03M

191.10%7.64M

585.45%5.74M

79.35%924.45K

-83.43%209.53K

14,899.56%756.88K

Net issuance payments of debt

-113.19%-15.19K

194.99%166.95K

-16.09%-29.67K

1,284.39%479.29K

-277.02%-631.76K

236.38%115.11K

-1,367.62%-175.75K

-116.05%-25.55K

-57.80%-40.47K

1,120.99%356.88K

Net common stock issuance

-105.50%-400K

--0

-300.00%-500K

-75.00%100K

168.54%7.27M

678.82%6.62M

--0

-80.62%250K

900.00%400K

Net other financing activities

----

---500K

--250K

---700K

----

Cash from discontinued financing activities

Financing cash flow

-105.44%-415.19K

-97.09%166.95K

-103.21%-29.67K

128.74%479.29K

-236.32%-1.03M

191.10%7.64M

585.45%5.74M

79.35%924.45K

-83.43%209.53K

14,899.56%756.88K

Net cash flow

Beginning cash position

3,356.85%3.75M

748.56%633.58K

1,613.49%1.13M

846.32%1.42M

3,356.85%3.75M

-81.62%108.57K

155.64%74.67K

-66.31%66K

124.98%150.32K

-81.62%108.57K

Current changes in cash

-154.79%-2M

-69.48%1.12M

-5,841.15%-497.36K

-245.79%-291.56K

-5,682.27%-2.33M

855.77%3.64M

4,534.95%3.68M

105.20%8.66K

-165.31%-84.32K

107.97%41.75K

End cash Position

-53.21%1.76M

748.56%633.58K

1,613.49%1.13M

846.32%1.42M

3,356.85%3.75M

155.64%74.67K

-66.31%66K

124.98%150.32K

Free cash flow

44.30%-2.22M

110.39%214.72K

48.93%-467.69K

-128.30%-670.85K

-81.62%-1.3M

-28.52%-3.99M

-172.05%-2.07M

-34.39%-915.78K

74.12%-293.85K

-35.18%-715.13K

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Oct 31, 2023	(Q4)Oct 31, 2023	(Q3)Jul 31, 2023	(Q2)Apr 30, 2023	(Q1)Jan 31, 2023	(FY)Oct 31, 2022	(Q4)Oct 31, 2022	(Q3)Jul 31, 2022	(Q2)Apr 30, 2022	(Q1)Jan 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	30.59%-2.2M	112.54%220.45K	40.82%-464.15K	-949.04%-670.85K	-129.06%-1.28M	-18.11%-3.17M	-214.18%-1.76M	-55.95%-784.3K	94.37%-63.95K	-16.00%-559.99K
Net income from continuing operations	21.47%-6.99M	63.87%-1.09M	40.69%-1.62M	-36.76%-1.99M	-35.01%-2.29M	30.26%-8.9M	-215.12%-3.02M	-93.59%-2.73M	34.98%-1.46M	79.22%-1.69M
Operating gains losses	---340.61K	----	----	----	----	----	----	----	----	----
Depreciation and amortization	46.27%486.35K	-93.72%16.5K	327.49%157.9K	739.34%156.16K	999.51%155.8K	530.92%332.51K	1,685.18%262.8K	181.42%36.94K	46.91%18.61K	16.22%14.17K
Other non cash items	35.49%368.19K	3.44%66.24K	363.79%154.05K	-72.28%61.63K	97.07%86.27K	--271.75K	--64.03K	---58.4K	--222.34K	--43.78K
Change In working capital	-43.48%788.1K	1,391.52%653.85K	154.10%47.54K	-66.36%299.91K	-138.98%-213.21K	1.69%1.39M	-43.86%43.84K	-122.13%-87.88K	758.79%891.56K	-46.97%546.9K
-Change in receivables	116.34%19.49K	99.20%-739	176.94%60.26K	-96.23%2.31K	-329.40%-42.35K	-59.46%-119.22K	-65.36%-92.48K	-361.50%-78.32K	425.33%61.44K	67.02%-9.86K
-Change in inventory	-20.60%-61.67K	68.33%-52.64K	-111.43%-5K	506.59%28.8K	-141.85%-32.83K	41.90%-51.14K	-2,047.10%-166.22K	148.90%43.72K	-27.92%-7.08K	4,966.75%78.45K
-Change in prepaid assets	184.21%99.59K	194.74%58.63K	302.04%92.36K	-139.09%-19.36K	46.77%-32.04K	-1,001.21%-118.26K	-244.55%-61.88K	-291.48%-45.71K	167.91%49.53K	-1,238.47%-60.19K
-Change in payables and accrued expense	-86.21%233.44K	-49.51%184.01K	-1,334.52%-108.54K	-65.96%268.14K	-120.10%-110.18K	10.26%1.69M	398.60%364.42K	-101.75%-7.57K	2,173.81%787.68K	-48.65%548.08K
-Change in other working capital	5,293.31%497.26K	--464.6K	--8.46K	--20.01K	143.81%4.2K	-200.00%-9.58K	--0	--0	--0	---9.58K
Cash from discontinued investing activities
Operating cash flow	30.59%-2.2M	112.54%220.45K	40.82%-464.15K	-949.04%-670.85K	-129.06%-1.28M	-18.11%-3.17M	-214.18%-1.76M	-55.95%-784.3K	94.37%-63.95K	-16.00%-559.99K
Investing cash flow
Cash flow from continuing investing activities	174.64%615.57K	338.53%735.22K	97.31%-3.54K	56.50%-100K	89.61%-16.12K	-94.18%-824.74K	-54.16%-308.22K	26.36%-131.48K	-229.9K	-235.32%-155.13K
Net PPE purchase and sale	96.92%-25.39K	98.14%-5.74K	97.31%-3.54K	100.00%1	89.61%-16.12K	-94.18%-824.74K	-54.16%-308.22K	26.36%-131.48K	---229.9K	-235.32%-155.13K
Net investment purchase and sale	---100K	--0	--0	----	----	--0	--0	--0	----	----
Net other investing changes	--740.96K	----	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	174.64%615.57K	338.53%735.22K	97.31%-3.54K	56.50%-100K	89.61%-16.12K	-94.18%-824.74K	-54.16%-308.22K	26.36%-131.48K	---229.9K	-235.32%-155.13K
Financing cash flow
Cash flow from continuing financing activities	-105.44%-415.19K	-97.09%166.95K	-103.21%-29.67K	128.74%479.29K	-236.32%-1.03M	191.10%7.64M	585.45%5.74M	79.35%924.45K	-83.43%209.53K	14,899.56%756.88K
Net issuance payments of debt	-113.19%-15.19K	194.99%166.95K	-16.09%-29.67K	1,284.39%479.29K	-277.02%-631.76K	236.38%115.11K	-1,367.62%-175.75K	-116.05%-25.55K	-57.80%-40.47K	1,120.99%356.88K
Net common stock issuance	-105.50%-400K	--0	--0	-300.00%-500K	-75.00%100K	168.54%7.27M	678.82%6.62M	--0	-80.62%250K	900.00%400K
Net other financing activities	----	----	----	----	---500K	--250K	---700K	----	----	----
Cash from discontinued financing activities
Financing cash flow	-105.44%-415.19K	-97.09%166.95K	-103.21%-29.67K	128.74%479.29K	-236.32%-1.03M	191.10%7.64M	585.45%5.74M	79.35%924.45K	-83.43%209.53K	14,899.56%756.88K
Net cash flow
Beginning cash position	3,356.85%3.75M	748.56%633.58K	1,613.49%1.13M	846.32%1.42M	3,356.85%3.75M	-81.62%108.57K	155.64%74.67K	-66.31%66K	124.98%150.32K	-81.62%108.57K
Current changes in cash	-154.79%-2M	-69.48%1.12M	-5,841.15%-497.36K	-245.79%-291.56K	-5,682.27%-2.33M	855.77%3.64M	4,534.95%3.68M	105.20%8.66K	-165.31%-84.32K	107.97%41.75K
End cash Position	-53.21%1.76M	-53.21%1.76M	748.56%633.58K	1,613.49%1.13M	846.32%1.42M	3,356.85%3.75M	3,356.85%3.75M	155.64%74.67K	-66.31%66K	124.98%150.32K
Free cash flow	44.30%-2.22M	110.39%214.72K	48.93%-467.69K	-128.30%-670.85K	-81.62%-1.3M	-28.52%-3.99M	-172.05%-2.07M	-34.39%-915.78K	74.12%-293.85K	-35.18%-715.13K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall